Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

REGN scores P&G top dollar

As “creative” deals become a buzzword, BioCentury looks back at a 1997 deal that helped keep Regeneron independent

By Ilan Zipkin, Staff Writer
February 22, 2023 12:08 AM UTC

As biotech plunges into an uncertain 2023, the pages of BioCentury reflect what’s on everyone’s mind: Survival. What will happen to the have-nots?

Will a house-cleaning get the sector back on financial tracks?...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Procter & Gamble Co.

Regeneron Pharmaceuticals Inc.